Mechanism of immunosuppression of the antirheumatic herb TWHf in human T cells

Journal of Rheumatology

Volumn 26, Issue 1, 1999, Pages 14-24

  Ho, Ling Jun ^a   Chang, Deh Ming ^a   Chang, Mu Lan ^a   Kuo, San Yuan ^a   Lai, Jenn Haung ^a  

^a TRI SERVICE GENERAL HOSPITAL   (Taiwan)

Author keywords

Apoptosis; Herb; Immunosuppression; Mechanism; T cells

Indexed keywords

ANTIRHEUMATIC AGENT; CD3 ANTIGEN; CD4 ANTIGEN; CD40 ANTIGEN; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; DNA FRAGMENT; ENDONUCLEASE; IMMUNOSUPPRESSIVE AGENT; INTERLEUKIN 2; INTERLEUKIN 2 RECEPTOR; IONOMYCIN; PHORBOL 13 ACETATE 12 MYRISTATE; PREDNISOLONE; T LYMPHOCYTE RECEPTOR; TRIPTERYGIUM WILFORDII EXTRACT; TRYPAN BLUE;

APOPTOSIS; ARTICLE; CELL SURVIVAL; CELL VIABILITY; CONTROLLED STUDY; DNA CONTENT; DRUG MECHANISM; ENZYME LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IMMUNOSUPPRESSIVE TREATMENT; LYMPHOCYTE PROLIFERATION; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; T LYMPHOCYTE;

ANTIGENS, CD28; ANTIGENS, CD3; ANTIGENS, CD4; ANTIGENS, CD40; ANTIRHEUMATIC AGENTS; APOPTOSIS; CALCIUM; CELL SURVIVAL; DOWN-REGULATION; DRUGS, CHINESE HERBAL; HUMANS; INTERLEUKIN-2; RECEPTORS, INTERLEUKIN-2; T-LYMPHOCYTES; TETRADECANOYLPHORBOL ACETATE;

EID: 0032891801     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (59)

1. Lipsky PE, Tao X-L. A potential new treatment for rheumatoid arthritis: thunder god vine. Semin Arthritis Rheum 1997;26:713-23.
2. Zhang LX, Yu FK, Zhang QY, Fang Z, Pan DJ. Immunosuppressive and anti-inflammatory activities of tripterine. Acta Pharmaceutica Sinica 1990;25:573-7.
3. Kupchan SM, Court WA, Dailey RG, Gilmore JC, Bryan RF. Triptolide and tripdiolide, novel antileukemic diterpenoid triepoxides from Tripterygium wilfordii. J Am Chem Soc 1972;94:7194-5.
4. Kupchan SM, Schubert RM. A biomimetic reaction of the antileukemic triptolides? Science 1974;185:791-2.
5. Tao X-L, Cai JJ, Lipsky PE. The identity of immunosuppressive components of the ethyl acetate extract and chloroform methanol extract (T2) of Tripterygium wilfordii Hook F. J Pharm Exp Ther 1995;272:1305-12.
6. Chang D-M, Chang W-Y, Kuo S-Y, Chang M-L. The effects of traditional antirheumatic herbal medicines on immune response cells. J Rheumatol 1997;24:436-41.
7. Tao X-L, Davis LS, Lipsky PE. Effect of an extract of the Chinese herbal remedy Tripterygium wilfordii Hook F on human immune responsiveness. Arthritis Rheum 1991;34:1274-81.
8. Fox DA. The role of T cells in the immunopathogenesis of rheumatoid arthritis. Arthritis Rheum 1997;40:598-609.
9. Moreland LW, Heck LW, Koopman WJ. Biologic agents for treating rheumatoid arthritis. Arthritis Rheum 1997;40:397-409.
10. Tugwell P, Pincus T, Yocum D, et al. Combination therapy with cyclosporin and methotrexate in severe rheumatoid arthritis. N Engl J Med 1995;333:137-41.
11. Sigal NH, Dumont FJ, Cyclosporin A, FK-506, and rapamycin: pharmacologic probes of lymphocyte signal transduction. Annu Rev Immunol 1992;67:31-40.
12. Bierer BE, Hollander G, Fruman D, Burakoff SJ. Cyclosporin A and FK506: molecular mechanisms of immunosuppression and probes for transplantation biology. Curr Opin Immunol 1993;5:763-73.
13. Bryan RG, Li Y, Lai J-H, et al. The effect of CD28 signal transduction on c-Rel in human peripheral blood T cells. Mol Cell Biol 1994;14:7933-42.
14. Arends MJ, Wyllie AH. Apoptosis: mechanism and roles in pathology. Int Rev Exp Pathol 1991;32:223-54.
15. Nicoletti I, Migliorati G, Pagliacci MC, Grignani F, Riccardi C. A rapid and simple method for measuring thymocyte apoptosis by propidium iodide staining and flow cytometry. J Immunol Methods 1991;139:271-9.
16. Tang W, Eisenbrand G, Chinese drugs of plant origin: chemistry, pharmacology, and use in traditional and modern medicine. Berlin: Springer-Verlag: 1992.
17. Wyllie AH. Glucocorticoid-induced thymocyte apoptosis is associated with endogenous endonuclease activation. Nature 1980;284:555-6.
18. Wyllie AH, Morris RG, Smith AL, Dunlop D. Chromatin cleavage in apoptosis: association with condensed chromatin morphology and dependence on macromolecular synthesis. J Pathol 1984;142:67-77.
19. Klaus SJ, Sidorenko SP, Clark EA. CD45 ligation induces programmed cell death in T and B lymphocytes. J Immunol 1996;156:2743-53.
20. Nakajima H, Golstein P, Henkart PA. The target cell nucleus is not required for cell-mediated granzyme-or Fas-based cytotoxicity. J Exp Med 1995;181:1905-9.
21. Schultze-Osthoff K, Walczak H, Droge W, Krammer PH. Cell nucleus and DNA fragmentation are not required for apoptosis. J Cell Biol 1994;127:15-20.
22. Cohen GM, Sun X, Snowden RT, Dinsdale D, Skilleter DN. Key morphological features of apoptosis may occur in the absence of internucleosomal DNA fragmentation. Biochem J 1992;286:331-4.
23. Truneh A, Albert F, Golstein P, Schmitt-Verhulst A-M. Early steps of lymphocyte activation bypass by synergy between calcium ionophores and phorbol ester. Nature 1985;313:318-20.
24. Lai J-H, Tan T-H. CD28 signaling causes a sustained down-regulation of IκBα which can be prevented by the immunosuppressant rapamycin. J Biol Chem 1994;269:30077-80.
25. June CH, Bluestone JA, Nadler LM, Thompson CB. The B7 and CD28 receptor families. Immunol Today 1994;15:321-31.
26. Ward SG. CD28: a signalling perspective. Biochemical J 1996;31:361-77.
27. Nusslein HG, Frosch K-H, Woith W, Lane P, Kalden JR, Manger B. Increase of intracellular calcium is the essential signal for the expression of CD40 ligand. Eur J Immunol 1996;26:846-50.
28. Cantrell DA, Davies AA, Crumpton MJ. Activators of protein kinase C down-regulate and phosphorylate the T3/T-cell antigen receptor complex of human T lymphocytes. Proc Natl Acad Sci USA 1985;82:8158-62.
29. Acres RB, Conlon PJ, Mochizuki DY, Gallis B. Rapid phosphorylation and modulation of the T4 antigen on cloned helper T cells induced by phorbol myristate acetate or antigen. J Biol Chem 1986;261:16210-4.
30. Jacobson MD, Weil M, Raff MC. Programmed cell death in animal development. Cell 1997;88:347-54.
31. Nagata S. Apoptosis by death factor. Cell 1997;88:355-65.
32. Sellins KS, Cohen JJ. Gene induction by gamma-irradiation leads to DNA fragmentation in lymphocytes. J Immunol 1987;139:3199-206.
33. Nakajima K, Aono H, Hasunuma T, et al. Apoptosis and functional Fas antigen in rheumatoid arthritis synoviocytes. Arthritis Rheum 1995;38:485-91.
34. Mountz JD, Wu J, Cheng J, Zhou T. Autoimmune diseases: a problem of defective apoptosis. Arthritis Rheum 1994;37:1415-20.
35. Cohen JJ, Duke RC. Glucocorticoid activation of a calcium-dependent endonuclease in the thymocyte leads to cell death. J Immunol 1984;132:38-42.
36. Meng XW, Feller JM, Ziegler JB, Pittman SM, Ireland CM. Induction of apoptosis in peripheral blood lymphocytes following treatment in vitro with hydroxychloroquine. Arthritis Rheum 1997;40:927-35.
37. Lu X-J, Xie W-L, Reed D, Bradshaw WS, Simmons DL. Nonsteroidal antiinflammatory drugs cause apoptosis and induce cyclooxygenases in chicken embryo fibroblasts. Proc Natl Acad Sci USA 1995;92:7961-5.
38. Tao XL, Davis LS, Hashimoto K, Lipsky PE. The Chinese herbal remedy, T2, inhibits mitogen-induced cytokine gene transcription by T cells, but not initial signal transduction. J Pharm Exp Ther 1996;276:316-25.
39. Cheng ZZ, Fang H. Quantitative determination of triptolide in common threewingnut (Tripterygium wilfordii) in different seasons and parts. Chin Trad Herb Drugs 1986;17:12-3.
40. Su Y, Shi Y-F, Shi Y-B. Cyclosporin A but not FK506 inhibits thyroid hormone-induced apoptosis in tadpole intestinal epithelium. FASEB J 1997;11:559-65.
41. Rühlmann A. Nordheim A. Effects of the immunosuppressive drugs CsA and FK506 on intracellular signalling and gene regulation. Immunobiol 1997;198:192-206.
42. Lai J-H, Horvath G, Subleski J, Bruder J, Ghosh P, Tan T-H. ReIA is a potent transcriptional activator of the CD28 response element within the interleukin 2 promoter. Moll Cell Biol 1995;15:4260-71.
43. Rudd CE. Upstream-downstream: CD28 signaling pathways and T cell function. Immunity 1996;4:527-34.
44. Finck BK, Linsley PS, Wofsy D. Treatment of murine lupus with CTLA41g. Science 1994;265:1225-7.
45. Lenschow DJ, Zeng Y, Thistlethwaite JR, et al. Long-term survival of xenogeneic pancreatic islet grafts induced by CTLA41g. Science 1992;257:789-92.
46. Azumu H, Chandraker A, Nadeau K, et al. Blockade of T-cell costimulation prevents development of experimental chronic renal allograft rejection. Proc Natl Acad Sci USA 1996;93:12439-44.
47. Onodera K, Chandraker A, Schaub M, et al. CD28-B7 T cell costimulatory blockade by CTLA41g in sensitized rat recipients. J Immunol 1997;159:1711-7.
48. Lenschow DJ, Walunas TL, Bluestone JA. CD28/B7 system of T cell costimulation. Annu Rev Immunol 1996;14:233-58.
49. Luo H, Chen H, Daloze P, St. Louis G, Wu J. Anti-CD28 antibody-and IL-4-induced human T cell proliferation is sensitive to rapamycin. Clin Exp Immunol 1993;94:371-6.
50. Bierer BE, Schreiber SL, Burakoff SJ. The effect of the immunosuppressant FK-506 on alternate pathways of T cell activation. Eur J Immunol 1991;21:439-45.
51. Lin Y, Goebels J, Rulgeerts O, et al. Use of the methylxanthine derivative A802715 in transplantation immunology. Transplantation 1997;63:1813-8.
52. Linsley PS, Ledbetter JA. The role of the CD28 receptor during T cell responses to antigen. Annu Rev Immunol 1993;11:191-212.
53. Nunes J, Klasen S, Ragueneau M, et al. CD28 mAbs with distinct binding properties differ in their ability to induce T cell activation: analysis of early and late activation events. Int Immunol 1993;5:311-5.
54. Ghosh P, Sica A, Cippitelli M, et al. Activation of nuclear factor of activated T cells in a cyclosporin A-resistant pathway. J Biol Chem 1996;271:7700-4.
55. Ruegg CL, Rajasekar S, Stein BS, Engleman EG. Degradation of CD4 following phorbol-induced internalization in human T lymphocytes. J Biol Chem 1992;267:18837-43.
56. Salio M, Valitutti S, Lanzavecchia A. Agonist-induced T cell receptor down-regulation: molecular requirement and dissociation from T cell activation. Eur J Immunol 1997;27:1769-73.
57. Tan TH, Huang GP, Sica A, et al. KB site-dependent activation of the interleukin-2 receptor alpha-chain gene promoter by human c-Rel. Mol Cell Biol 1992;12:4067-75.
58. American College of Rheumatology AD HOC Committee on Clinical Guidelines. Guidelines for the management of rheumatoid arthritis. Arthritis Rheum 1996;39:713-22.
59. O'Dell JR, Haire CE, Erikson N, et al. Treatment of rheumatoid arthritis with methotrexate alone, sulfasalazine and hydroxychloroquine, or a combination of all three medications. N Engl J Med 1996;334:1287-91.